Eramol

UK pharmaceutical CDMO founded by two Qualified Persons (QPs), specializing in end-to-end clinical trial supply services. Offers formulation development, primary and secondary packaging, QP release, clinical supply chain management and global distribution via approved depots in North & South America, Australasia and Southeast Asia. MHRA and HPRA approved facilities.